OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Neurotherapeutics is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men	56
The relevance of cortical thickness in migraine sufferers and implications to therapy	50
Steps to manage treatment-refractory migraine in adults	47
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives	35
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease	34
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?	34
The latest developments with internet-based psychological treatments for depression	33
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study	32
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review	32
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis	32
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms	31
Where Art Thou O treatment for diabetic neuropathy: the sequel	31
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?	30
Advances in the treatment and management of frontotemporal dementia	29
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents	28
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 2025	28
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia	27
The value and risks of antidepressant therapy in Alzheimer’s disease: a field update and its clinical implications	26
Acute and long-term cognitive impairment following sepsis: mechanism and prevention	26
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead	25
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor	25
Why is ADHD so difficult to diagnose in older adults?	25
Hesitancies in primary headaches treatments	25
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms	24